deguelin has been researched along with sb 202190 in 3 studies
| Studies (deguelin) | Trials (deguelin) | Recent Studies (post-2010) (deguelin) | Studies (sb 202190) | Trials (sb 202190) | Recent Studies (post-2010) (sb 202190) |
|---|---|---|---|---|---|
| 182 | 0 | 115 | 651 | 0 | 202 |
| Protein | Taxonomy | deguelin (IC50) | sb 202190 (IC50) |
|---|---|---|---|
| Mitogen-activated protein kinase 13 | Homo sapiens (human) | 0.08 | |
| Bromodomain-containing protein 4 | Homo sapiens (human) | 2.95 | |
| Tyrosinase | Mus musculus (house mouse) | 0.03 | |
| Amine oxidase [flavin-containing] B | Rattus norvegicus (Norway rat) | 0.08 | |
| Casein kinase I isoform delta | Homo sapiens (human) | 0.188 | |
| Mitogen-activated protein kinase 12 | Homo sapiens (human) | 0.08 | |
| Mitogen-activated protein kinase 11 | Homo sapiens (human) | 0.1038 | |
| Mitogen-activated protein kinase 14 | Homo sapiens (human) | 0.0625 | |
| Tau-tubulin kinase 2 | Homo sapiens (human) | 9.34 | |
| large T antigen | Betapolyomavirus macacae | 4.87 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
| Boggs, N; Boyd, J; Currie, HN; Vrana, JA | 1 |
| Boggs, N; Boyd, JW; Currie, HN; Han, AA; Scardoni, G; Vrana, JA | 1 |
3 other study(ies) available for deguelin and sb 202190
| Article | Year |
|---|---|
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |
Amelioration of an undesired action of deguelin.
Topics: Apoptosis; Dose-Response Relationship, Drug; Enzyme Inhibitors; Hep G2 Cells; Humans; Imidazoles; Oxygen; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Plant Extracts; Pyridines; Rotenone; Structure-Activity Relationship | 2013 |
An approach to investigate intracellular protein network responses.
Topics: Cell Survival; Dose-Response Relationship, Drug; Hep G2 Cells; Humans; Imidazoles; MAP Kinase Signaling System; Mitochondria; Mitogen-Activated Protein Kinases; Oxidative Stress; Phosphorylation; Protein Kinase Inhibitors; Pyridines; Rotenone; Structure-Activity Relationship; Toxicity Tests; Tumor Cells, Cultured | 2014 |